Target Price | $368.96 |
Price | $283.06 |
Potential | 30.35% |
Number of Estimates | 27 |
27 Analysts have issued a price target Lululemon Athletica 2026 . The average Lululemon Athletica target price is $368.96. This is 30.35% higher than the current stock price. The highest price target is $500.00 76.64% , the lowest is $194.00 31.46% . | |
A rating was issued by 34 analysts: 19 Analysts recommend Lululemon Athletica to buy, 12 to hold and 3 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Lululemon Athletica stock has an average upside potential 2026 of 30.35% . Most analysts recommend the Lululemon Athletica stock at Purchase. |
29 Analysts have issued a sales forecast Lululemon Athletica 2026 . The average Lululemon Athletica sales estimate is $11.3b . This is 6.42% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $11.5b 8.61% , the lowest is $10.7b 1.44% .
This results in the following potential growth metrics:
2025 | $10.6b | 10.07% |
---|---|---|
2026 | $11.3b | 6.42% |
2027 | $12.2b | 8.06% |
2028 | $13.0b | 6.84% |
2029 | $13.9b | 6.95% |
2030 | $14.8b | 6.15% |
24 Analysts have issued an Lululemon Athletica EBITDA forecast 2026. The average Lululemon Athletica EBITDA estimate is $3.0b . This is 1.20% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $3.2b 6.54% , the lowest is $2.7b 9.87% .
This results in the following potential growth metrics and future EBITDA Margins:
2025 | $2.9b | 13.89% |
---|---|---|
2026 | $3.0b | 3.31% |
2027 | $3.2b | 6.72% |
2028 | $3.5b | 7.14% |
2029 | $3.9b | 11.48% |
2030 | $4.1b | 6.70% |
2025 | 27.83% | 3.47% |
---|---|---|
2026 | 27.01% | 2.93% |
2027 | 26.68% | 1.22% |
2028 | 26.75% | 0.26% |
2029 | 27.89% | 4.26% |
2030 | 28.03% | 0.50% |
11 Lululemon Athletica Analysts have issued a net profit forecast 2026. The average Lululemon Athletica net profit estimate is $1.8b . This is 2.63% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $1.9b 6.86% , the lowest is $1.6b 11.00% .
This results in the following potential growth metrics and future Net Margins:
2025 | $1.8b | 20.00% |
---|---|---|
2026 | $1.8b | 3.26% |
2027 | $2.0b | 9.62% |
2028 | $2.1b | 3.19% |
2029 | $2.6b | 26.79% |
2030 | $2.9b | 11.25% |
2025 | 16.77% | 9.02% |
---|---|---|
2026 | 16.27% | 2.98% |
2027 | 16.51% | 1.48% |
2028 | 15.94% | 3.45% |
2029 | 18.90% | 18.57% |
2030 | 19.81% | 4.81% |
11 Analysts have issued a Lululemon Athletica forecast for earnings per share. The average Lululemon Athletica EPS is $15.12 . This is 2.65% higher than earnings per share in the financial year 2025. The highest EPS forecast is $15.74 6.86% , the lowest is $13.11 11.00% .
This results in the following potential growth metrics and future valuations:
2025 | $14.64 | 20.00% |
---|---|---|
2026 | $15.12 | 3.28% |
2027 | $16.57 | 9.59% |
2028 | $17.10 | 3.20% |
2029 | $21.68 | 26.78% |
2030 | $24.12 | 11.25% |
Current | 19.90 | 39.73% |
---|---|---|
2026 | 19.39 | 2.56% |
2027 | 17.68 | 8.82% |
2028 | 17.14 | 3.05% |
2029 | 13.52 | 21.12% |
2030 | 12.15 | 10.13% |
Based on analysts' sales estimates for 2026, the Lululemon Athletica stock is valued at an EV/Sales of 3.13 and an P/S ratio of 3.17 .
This results in the following potential growth metrics and future valuations:
Current | 3.33 | 35.96% |
---|---|---|
2026 | 3.13 | 5.97% |
2027 | 2.90 | 7.45% |
2028 | 2.71 | 6.40% |
2029 | 2.54 | 6.50% |
2030 | 2.39 | 5.79% |
Current | 3.37 | 36.27% |
---|---|---|
2026 | 3.17 | 6.03% |
2027 | 2.93 | 7.46% |
2028 | 2.74 | 6.40% |
2029 | 2.57 | 6.50% |
2030 | 2.42 | 5.79% |
Lululemon Athletica...
Analyst | Rating | Action | Date |
---|---|---|---|
JP Morgan |
Overweight
➜
Overweight
|
Unchanged | Mar 28 2025 |
B of A Securities |
Buy
➜
Buy
|
Unchanged | Mar 28 2025 |
BMO Capital |
Market Perform
➜
Market Perform
|
Unchanged | Mar 28 2025 |
Needham |
Buy
➜
Buy
|
Unchanged | Mar 28 2025 |
Wells Fargo |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Mar 28 2025 |
Morgan Stanley |
Overweight
➜
Overweight
|
Unchanged | Mar 28 2025 |
Keybanc |
Overweight
➜
Overweight
|
Unchanged | Mar 28 2025 |
Analyst Rating | Date |
---|---|
Unchanged
JP Morgan:
Overweight
➜
Overweight
|
Mar 28 2025 |
Unchanged
B of A Securities:
Buy
➜
Buy
|
Mar 28 2025 |
Unchanged
BMO Capital:
Market Perform
➜
Market Perform
|
Mar 28 2025 |
Unchanged
Needham:
Buy
➜
Buy
|
Mar 28 2025 |
Unchanged
Wells Fargo:
Equal-Weight
➜
Equal-Weight
|
Mar 28 2025 |
Unchanged
Morgan Stanley:
Overweight
➜
Overweight
|
Mar 28 2025 |
Unchanged
Keybanc:
Overweight
➜
Overweight
|
Mar 28 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.